Activating mutations in PIK3CA, the gene encoding the catalytic p110α subunit of PI3Kα, are also considered disease-drivers in human cancers as well as developmental overgrowth disorders known as PROS (PIK3CA-related overgrowth spectrum) [3]. Here, PIK3CA is linked to cancer.